Catalyst Wire Dossier Catalyst Wire Dossier

PRTH-101

· Incendia Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRTH-101, covering 2026-02-23 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies [Phase 1]

See pricing